SEMA3A and neoplasm: Evodiamine, a natural anti‐tumour compound,172 inhibits the lactylation modification of hypoxia inducible factor 1 subunit alpha (HIF1a) by suppressing intracellular lactate production, thereby weakening HIF1a's inhibitory function on Sema3A.